SOPHiA GENETICS is proud to participate in the 50th National Congress of the Mexican Association of Human Genetics (AMGH) and the 9th Latin American Congress of Human Genetics, organized by AMGH and the Red Latinoamericana de Genética Humana.

📅 November 12–14, 2025

📍 Hotel Sheraton Buganvilias, Puerto Vallarta, Jalisco, Mexico

As a global leader in data-driven medicine, we are thrilled to join this milestone event, bringing together experts, researchers, and clinicians from across Latin America.

📍 Visit us at Booth 6

Our team will be on-site to showcase how the SOPHiA DDM™ Platform transforms complex genomic data into actionable insights—empowering healthcare professionals to accelerate discovery, enhance diagnosis, and drive precision medicine forward.

We’re excited to be part of the 36th Brazilian Congress of Medical Genetics, joining experts, researchers, and clinicians from Brazil. Our focus this year is on presenting the most recent launch — SOPHiA DDM™ Enhanced Exome Solutions. Visit us at booth #3 to learn how our technology can empower your work in medical genetics.

SOPHiA GENETICS is pleased to announce its participation in the upcoming HGSA 2025 Congress, taking place in Sydney, Australia. As a leader in data-driven medicine, we look forward to engaging with the genetics and healthcare community at this prominent event.

We invite all attendees to visit us at Booth #5 to discover the latest innovations in our New Generation SOPHiA DDM™ Platform. Our showcase will highlight significant advancements in exome sequencing, as well as our cutting-edge oncology solutions, including MSK-ACCESS® and MSK-IMPACT®, both powered by SOPHiA DDM™.

Join us to learn how SOPHiA GENETICS is advancing precision medicine through robust, multimodal, and globally applicable solutions.

SOPHiA GENETICS is proud to participate in the 70th Anniversary of the SBG Congress, taking place in Belém, Brazil, in 2025. As a global leader in data-driven medicine, we are thrilled to engage with the genetics and healthcare communities at this landmark event.

📍 Visit us at Booth #5

Our team will be on-site to showcase how SOPHiA GENETICS is transforming complex genomic data into actionable insights—empowering clinicians and researchers worldwide.

Discover the New Generation SOPHiA DDM™ Platform

Explore our most recent innovations in Exome Sequencing, and learn how they are advancing the diagnosis and resolution of complex genetic cases.

Save the date! Corporate Workshop

Date: August 15
Time: 1:00 pm - 2:00 pm
Hangar 2 Room

Title: Unraveling Complex Genetic Disorders via Exome Sequencing

Speakers:

Dra. Ilana Zalcberg Renault, Onco-hematologist, Dasa Genômica
Bruno Piovezan, Subject Matter Expert, SOPHiA GENETICS

Hereditary cancer risk assessment is a rapidly advancing field, driven by the need for comprehensive variant detection, streamlined genomic workflows, and alignment with evolving guidelines. In the UK, testing is delivered through the NHS Genomic Laboratory Hub network, with each lab supporting a broad range of clinical indications under the National Genomic Test Directory. This webinar will highlight the experience of the West Midlands Genomic Laboratory in implementing a next-generation sequencing (NGS) solution for hereditary cancer. The session will detail how transitioning to the SOPHiA DDM™ Platform enabled the lab to improve turnaround, reduce hands-on time, and enhance variant detection. Featuring a practical walkthrough of the SOPHiA DDM™ analysis workflow, the presentation will guide attendees through each stage — from quality control to the identification of challenging variants —  concluding with a preview of the new generation of SOPHiA DDM™ platform and a glimpse into the lab’s future plans for continued innovation.

Learning Objectives

• Understand the impact of adopting an integrated NGS-based solution for hereditary cancer within a high-throughput genomic laboratory setting.
• Explore the full variant analysis workflow in SOPHiA DDM™, including quality control, filtering, classification, and CNV interpretation.
• Preview the new generation of SOPHiA DDM™, designed to enhance flexibility and compliance with variant interpretation frameworks.

As the global healthcare research landscape evolves at lightning speed, we need to change the way we approach healthcare data by breaking down silos, fostering knowledge sharing, and democratizing access to anonymized real-world health insights. And as the volume and complexity of healthcare data continue to grow, the integration of next-generation data analytics and artificial intelligence is reshaping germline variant analysis, offering researchers the tools to uncover actionable insights, streamline processes, and tackle some of the field’s most pressing challenges.

This webcast will explore how to unlock the potential of germline research with cutting-edge advancements in AI-powered workflows, highlighting the New Generation SOPHiA DDM Platform.

Built by users, for users, this AI-powered platform unites healthcare institutions worldwide, paving the way for a future of collective intelligence in precision medicine by streamling sequencing data analysis and interpretation, simplifying variant prioritization, and accelerating reporting.

What will you learn?

• The latest breakthroughs in AI applications for germline research
• Strategies for enhancing data accuracy, scalability, and speed
• Real-world examples of how AI-driven workflows are solving complex research problems

Watch on-demand the webinar “Maximizing Efficiency: Implementing an Enhanced Exome Solution Across Multiple Indications”, where Dr. Eirikur Briem, Head of Department of Genetics and Molecular Medicine at the Landspitali University Hospital in Iceland presents his institute’s experience in implementing the SOPHiA DDM™ Enhanced Exome Solutions.

SOPHiA GENETICS is excited to join the ACGH 2025 Congress in Cartagena, Colombia! Meet us at booth #15 to discover the latest innovations of the New Generation SOPHiA DDM™ Platform, with a special focus on Exome advancements. This event is a key milestone for the scientific and academic community, reinforcing Colombia’s leadership in human genetics. Let’s shape the future of genomics together!

Save the date! Sponsored Academic Lunch

June 12th | 1:00-2:00pm | Room 3

Title
From Data to Diagnosis: The Impact of Enhanced Exomes in Precision Medicine

Speakers

• Carlos Santamaría, Jefe de División de Diagnóstico Molecular, Laboratorio Clínico Hospital Nacional de Niños, San José, Costa Rica
• Sevana Yaghoubian, MSc – Global Product Senior Director, Genomics, SOPHiA GENETICS.

SOPHiA GENETICS is thrilled to return for ACMG 2025! Visit us at booth #322 to learn more about our SOPHiA DDM™ and Alamut™ Visual Plus platforms for rare and inherited diseases.

Exhibit Theater
Friday, March 21.
11:20 am – 11:50 am.
Theatre 2

Streamlining genomic complexity with SOPHiA DDM™ and Alamut™ Visual Plus

Elexandra Barboza Arguedas, National Children’s Hospital, CCSS, University of Costa Rica, University of Medical Sciences.

Sevana Yaghoubian, MSc - Senior Director of Product Management, SOPHiA GENETICS.

Discover how our AI-powered platform is transforming germline variant analysis and interpretation, enabling scientists to uncover actionable insights with unmatched accuracy and efficiency. This session showcases the innovative features of the new-generation SOPHiA DDM™ Platform and the latest advancements in Alamut™ Visual Plus, purpose-built to optimize workflows and drive impactful outcomes.

Through the perspective of a medical laboratory scientist, discover SOPHiA DDM™’s capabilities for hereditary cancer and exome applications. Experience how its dedicated features set new standards in the assessment of even the most challenging variants and get an exclusive look at exciting functionalities debuting this year.

SOPHiA GENETICS is thrilled to be back at ESHG 2025! Come meet our team to learn how SOPHiA GENETICS can help turn complex generic data into life-changing Insights!